Cellectricon sues Fluxion Biosciences for patent infringement
05 February 2010
Maria Bailey
Please Login to read the full article.
05 February 2010
Maria Bailey
maria.bailey@informa.com
The Swedish biotech company Cellectricon has resumed litigation against Fluxion Biosciences of the US, alleging infringement of its four US patents. It first filed the lawsuit in a district court in California last July. Fluxion said it would defend this lawsuit vigorously.
Cellectricon claimed...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Amylin sues over Lilly's each-way diabetes bet on exenatide and BI's linagliptin
- US Capitol Capsule: NIH confesses error on unapproved drugs, but sets no deadline for changes
- Napo wins small battle in crofelemer dispute, but war rages on with Salix
- Lawyers call on government to spike Bayer’s slow death compulsory licenses tactics
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
